新闻稿

Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June

SAN DIEGO--(BUSINESS WIRE)--May. 30, 2012-- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentations at two upcoming investment conferences.

Illumina will webcast its presentation at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California, on June 6, 2012. The live webcast is scheduled to begin at 12:20 p.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session.

Illumina will also webcast its presentation at the William Blair & Company Growth Stock Conference in Chicago, Illinois on June 13, 2012. The live webcast is scheduled to begin at 9:40 a.m. ET and will feature an overview of the company by Christian Henry, Senior Vice President and General Manager, Genomic Solutions, followed by a question and answer session.

These webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

Source: Illumina, Inc.

Illumina, Inc.
Investors:
Kevin Williams, MD
Investor Relations
858-332-4989
kwilliams@illumina.com
or
Media:
Jennifer Temple
Public Relations
858-429-8350
PR@illumina.com

近期文章

因美纳员工如何推动医疗保健向精准医学迈进
因美纳员工如何推动医疗保健向精准医学迈进
多组学助力区分疑难卵巢癌病例中的良性和恶性肿瘤
多组学助力区分疑难卵巢癌病例中的良性和恶性肿瘤
多组学技术赋能青年科研力量,加速科研源头创新与转化
多组学技术赋能青年科研力量,加速科研源头创新与转化